February 10, 2026 02:09 pm (IST)
Follow us:
GlaxoSmithKline records 8% growth
New Delhi, Aug 6 (IBNS): GlaxoSmithKline Consumer Healthcare Limited on Wednesday declared its financial results for the first quarter ended June 30, 2014, where it recorded its net sales at Rs 922 crores, making a growth of 8% over 2013 with PAT at Rs. 130 crores growing by 9% for the same period and PBT at Rs 198 crores growing by 9%.
Commenting on the results, Zubair Ahmed, Managing Director, GlaxoSmithKline Consumer Healthcare Limited said, “We are proud to deliver consistent growth ahead of the category. This is significant in a scenario where consumption pattern is being impacted by inflation. Our sciences based products with its superior value, continue to remain relevant for our large consumer base."
"As a market leader we are also growing the category with successful launches of new products which are driving up consumption experiences. Our focused access strategy ensures that consumption and penetration has been the enabler for growth. Customer driven innovations and clutter breaking marketing based on sharp consumer insights will continue to be our driving force in the coming months to bring in more consumers closer to the product," he said.
The company also noted that in a recent addition to the Board of Directors, Sangeeta Talwar has been appointed as an Independent Director in casual vacancy created by the resignation of Ireena Vittal.
Support Our Journalism
We cannot do without you.. your contribution supports unbiased journalism
IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.
Support objective journalism for a small contribution.
Latest Headlines
India must push for energy independence amid global uncertainty: Vedanta chairman Anil Agarwal
Mon, Feb 09 2026
JK Tyre stock rallies on robust Q3 results, margins expand sharply
Mon, Feb 09 2026
India-US trade deal: ‘Negotiations always two-way’, says Amul MD amid farmers’ concerns
Mon, Feb 09 2026